SCHEMBL863405

SCHEMBL863405

O=C(O)N(Cc1ccccc1)Cc1nnc(-c2ccc(OCc3ccccc3)cc2)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 2/20 0.56
GAA P10253 2/20 0.56
SI P14410 2/20 0.56
MGAM2 Q2M2H8 2/20 0.56
ALOX5 P09917 3/20 0.50
PTGS1 P23219 1/20 0.50
PTGS2 P35354 1/20 0.50
NR4A2 P43354 2/20 0.48
PTGES O14684 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
MAOB P27338 1/20 0.46
NR4A1 P22736 1/20 0.45
NR4A3 Q92570 1/20 0.45
FFAR1 O14842 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12473329 0.80 MGAM (0.57) MGAMGAASIMGAM2NR4A2
SCHEMBL864263 0.75 HPGD (0.54) GAAALOX5PTGS1PTGS2PTGES
SCHEMBL3832934 0.74 GAA (0.71) MGAMGAASIMGAM2PTGS1
Bicarbonate SCHEMBL9638235 0.70 FFAR1 (0.71) PTGS1PTGS2NR4A2MAOBNR4A1
SCHEMBL23120532 0.69 LTA4H (0.64) ALOX5PTGS1PTGS2NR4A2PTGES
SCHEMBL23120176 0.69 ALOX5 (0.56) ALOX5PTGS1PTGS2NR4A2PTGES
SCHEMBL10465707 0.68 ALOX5 (0.58) ALOX5PTGS1PTGS2NR4A2L3MBTL1
SCHEMBL197017 0.67 LMNA (0.72) MGAMGAASIMGAM2ALOX5
SCHEMBL825414 0.67 LMNA (0.63) ALOX5MEN1NPC1RAB9AKMT2A
SCHEMBL9707249 0.67 ALOX5 (1.00) ALOX5PTGS1PTGS2NR4A2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476302-B2 α-ketoamide derivatives useful endothelial lipase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2013-07-02 US disclosed
US-20120077847-A1 ALPHA-KETOAMIDE DERIVATIVES USEFUL ENDOTHELIAL LIPASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077847-A1 ALPHA-KETOAMIDE DERIVATIVES USEFUL ENDOTHELIAL LIPASE INHIBITORS LIPG, LIPA, LIPE MGAM 50/4885GAA 29/4885SI 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.